Sigma Healthcare Limited (SIG.AX) Stock Analysis & Winston Score
Sigma Healthcare is an Australian company that supplies medicines and health products to pharmacies across Australia. It distributes prescription drugs, over-the-counter medicines, and general health goods to thousands of independent and branded pharmacy stores. Sigma is one of Australia's largest pharmaceutical wholesalers and also supports the Amcal and Guardian pharmacy banner networks. The company earns money by buying medicines in bulk from manufacturers and selling them to pharmacies at a markup, keeping a small margin on each transaction. It operates almost entirely within Australia and recently completed a major merger with Chemist Warehouse, one of Australia's largest retail pharmacy chains, significantly expanding its scale. The key growth opportunity is capturing more volume through the Chemist Warehouse relationship, but the main risk is that thin distribution margins leave little room for error if costs rise or pricing pressure increases from suppliers or competitors.
Winston Score: 38/100 — Below Average
Below-average fundamentals — multiple weak pillars.
- Quality: Mixed (8/30)
- Growth: Mixed (7/20)
- Cash Flow: Weak (2/10)
- Stability: Strong (8/10)
- Valuation: Data not available (0/10)
- Ownership: Good (10/15)
Key Facts
Price: 2.90 AUD
Market Cap: 33.5B AUD
Sector: Healthcare
Industry: Medical - Distribution
Exchange: Australian Securities Exchange

